Session 1T

Aging and Immunity

1:00 PM to 2:30 PM | Moderated by Matt Kaeberlein


The Potent Immunostimulatory Properties of Flagellin Suggest Novel Adjuvant Possibilities for Flagellin-Based Vaccines
Presenter
  • Kathryn Elizabeth (Kathryn) Boddy, Senior, Spanish, Biology (General)
Mentor
  • Kelly Smith,
Session
  • 1:00 PM to 2:30 PM

The Potent Immunostimulatory Properties of Flagellin Suggest Novel Adjuvant Possibilities for Flagellin-Based Vaccinesclose

Flagellin is a potent immunostimulant that is composed of 4 discrete domains. These are D1, which is recognized by Toll-like receptor-5 (TLR5), D0, which is recognized by Naip5 and IPAF, and D2 and D3, which are recognized by antibodies. Thus flagellin possesses both domains that activate the innate immune system and regions that are targeted by antibodies, so flagellin has potential to be engineered as a recombinant immunogen in vaccines. We hypothesize that we can replace the flagellin D3 domain with new antigens of interest while conserving protein structures required to activate TLR5 and Naip5/IPAF. To this end I have cloned a mutant FliC gene into a pTrC99a vector. This mutant FliC gene has replaced the D3 region with an HIV epitope that is recognized by broadly cross reacting and neutralizing antibodies. I will transform non-motile Salmonella typhimurium that lacks endogenous flagellin with this plasmid, and then determine whether this mutant flagellin molecule is produced, secreted and capable of restoring motility. If this mutant flagellin is properly expressed in S. typhimurium, future studies will be undertaken to test efficacy using vaccination studies in mice.


Ribosomal Protein Deficiency in C. elegans as a Model for Human Ribosomopathies
Presenter
  • Devon Brian (Devon) Chandler-Brown, Senior, Biology (General), Biochemistry Goldwater Scholar, Mary Gates Scholar
Mentors
  • Matt Kaeberlein,
  • Lara Shamieh, , Regis University
Session
  • 1:00 PM to 2:30 PM

Ribosomal Protein Deficiency in C. elegans as a Model for Human Ribosomopathiesclose

Ribosomopathies are a class of dominant, heritable diseases caused by inactivation of ribosomal components or processing factors. These diseases include Diamond-Blackfan anemia and -5q Syndrome, characterized by marrow failure and structural abnormalities, which have been linked to loss of function in both large and small ribosomal subunits. Inactivation of the p53 tumor suppressor is sufficient to block defects in hematopoiesis, suggesting that excessive p53 activity is at least partly responsible for these phenotypes. The nematode C. elegans has been a valuable model organism for a number of human diseases. Here we report that inactivation of large and small subunit ribosomal components (RPs) in C. elegans leads to an age-associated loss of body wall integrity and extrusion of the gonad termed “rupture”. We hypothesize that this phenotype shares a similar mechanism of pathology as seen in human diseases of ribosome deficiency, and that this may provide a useful nematode model for understanding the genetic and biochemical basis of ribosomapathies. Consistent with this hypothesis, deletion or knockdown of the C. elegans p53 ortholog, cep-1, attenuates the rate of rupture. It has been proposed that the human defect is due to aberrant p53-dependent activation of programmed cell death (PCD) machinery, however loss of the cell death effector ced-3 in nematodes does not block the increased rupture caused by RP deficiency. This suggests that RP loss either causes cell death by a non-canonical pathway or by a non-PCD-dependent mechanism. Alternatively, the CEP-1-dependent rupture may not result from cell death. Further experiments examining changes in p53 and its downstream effectors in the context of RP depletion will help elucidate the disease causing mechanisms. Understanding the effects of RP inactivation in C. elegans will provide a basis for developing treatments for the human disease.


Mutations, Oxidative Damage and Accelerated Aging in Werner Syndrome
Presenter
  • Jordon Michael (Jordon) Inloes, Junior, Biochemistry, Biology (General) Howard Hughes Scholar, Mary Gates Scholar
Mentors
  • Lawrence Loeb,
  • Edward Fox,
Session
  • 1:00 PM to 2:30 PM

Mutations, Oxidative Damage and Accelerated Aging in Werner Syndromeclose

Werner Syndrome (WS) results in a severe premature aging phenotype caused by an inherited mutation in the nuclear RecQ helicase WRN. The molecular pathogenesis of WS, however, remains unclear. The mitochondrial theory of aging states that aging is, in part, the culmination of a vicious cycle wherein mitochondrial DNA (mtDNA) mutations alter the electron transport chain leading to the inappropriate production of reactive oxygen species which then leads to widespread cellular damage and dysfunction. These oxidative species can react with mtDNA itself, resulting in further mutations which, in turn, fuels the cycle. We proposed to investigate if WS pathogenesis has a mitochondrial component. Our initial findings in cell lines derived from Werner Syndrome families suggest an association between Werner Syndrome and increased mtDNA mutations. Subsequently we have used the Random Mutation Capture (RMC) assay to quantify the frequency of point mutations and mtDNA content in cells depleted of WRN by shRNA. In addition, we have designed experiments to assay the levels of oxidative damage to both DNA and lipids using high-performance liquid chromatography and enzyme-linked immunosorbent assay (ELISA), respectively. With these experiments we hope to delineate any possible contribution of mitochondrial dysfunction to the pathogenesis of Werner Syndrome.


UV-Induced Toxicity of Ethosuximide
Presenters
  • Heather Lindsay (Heather) Schneider, Junior, Pre-Sciences
  • Erin Marie McCarthy, Junior, Biology (Physiology)
Mentors
  • Lara Shamieh, , Regis University
  • Matt Kaeberlein,
Session
  • 1:00 PM to 2:30 PM

UV-Induced Toxicity of Ethosuximideclose

Ethosuximide is T-type calcium channel inhibitor whose anticonvulsant properties have been used in the clinical treatment of petit mal epileptic seizures in humans. In addition to its clinical use, ethosuximide has also been found to increase lifespan in an invertebrate model organism, the nematode, Caenorhabditis elegans. While the therapeutic benefits of ethosuximide are promising, we have discovered that its breakdown in the presence of 254 nm ultra-violet (UV) light results in formation of a toxic by-product. Acute exposure of C. elegans to ethosuximide treated with UV light results in death at lower dosages compared to nematodes treated with the control, native compound. This effect is unique to ethosuximide, as several related anticonvulsant compounds do not exhibit similar toxicity. Ethosuximide toxicity is heightened in specific chemosensation mutants with defective neuronal signaling. To further test whether neurons are particularly sensitive to UV-treated ethosuximide, we are examining the effect of UV-treated ethosuximide on rat neuronal cells in culture. Interestingly, some human patients taking ethosuximide experience a butterfly rash under the eyes following exposure to sunlight. We speculate that this rash may be indicative of a similar mechanism of UV-induced toxicity occurring in these patients. Taken together, these studies will help elucidate the mechanism of toxicity resulting from exposure of ethosuximide to UV light.


The Localization of Wild-Type (wt) and Mutant (mt) Presenilin 2 in Microglia
Presenter
  • Michelina Diona (Miki) Stoddard, Senior, Neuroscience Mary Gates Scholar
Mentors
  • Gwenn Garden,
  • Suman Jayadev,
Session
  • 1:00 PM to 2:30 PM

The Localization of Wild-Type (wt) and Mutant (mt) Presenilin 2 in Microgliaclose

Autosomal dominant familial Alzheimer’s Disease (fAD) has been linked to mutations in genes encoding amyloid precursor protein, presenilin 1 (PS1) and presenilin 2 (PS2). Both PS proteins can act as the enzymatically active subunit of the gamma-secretase complex (γ-SC), a protein complex with intra-membrane proteolytic activity. It has been considered that PS2 is redundant to PS1 activity. However, data demonstrate that PS2 performs functions distinct from PS1. In addition, our laboratory recently reported that PS2 alone largely mediates γ-SC activity in microglia, and that PS2 influences the microglial response to pro-inflammatory stimuli. Given these findings and previous work demonstrating that microglia participate in AD pathogenesis, we queried whether mutations in the gene for PS2 altered its intracellular localization. Studies have shown that γ-SC localization may impact activity and substrate specificity. We hypothesized that 1) PS2 mutations may alter sub-cellular localization, and 2) sub-cellular localization of PS2 in microglia will provide insight into its cell-type specific functions. I created lentiviral vectors expressing PS2/eGFP fusion proteins that allow us to track PS2 localization. One vector contains PS2wt/eGFP, and the other PS2N141I/eGFP (a fAD-associated mutation). I will determine which organelles PS2 localizes to by confocal microscopy of microglia infected with these vectors and co-labeled with plasma membrane, endoplasmic reticulum, and mitochondrial markers. Future directions on this topic will include experimentation with amyloid-β (Aβ). Aβ plaques are a pathological hallmark of AD that attract and activate microglia. To determine whether Aβ exposure alters wtPS2 localization I will expose microglia infected with PS2wt/eGFP expressing lentivirus to Aβ and fix them at specific time intervals. I will image them and compare organelle marker co-localization of PS2 in Aβ-exposed cells to co-localization in cells treated with a control peptide. This will tell us whether Aβ alters PS2 localization in microglia.


The University of Washington is committed to providing access and accommodation in its services, programs, and activities. To make a request connected to a disability or health condition contact the Office of Undergraduate Research at undergradresearch@uw.edu or the Disability Services Office at least ten days in advance.